OptiMega-3® Q10

• Optimal EPA/DHA ratio of 2:1 in a highly bioavailable softgel
  
• Provides 600 mg of EPA, 300 mg of DHA, and 100 mg of CoQ10 per softgel
  
• Pharmaceutical-grade omega-3 blend, USP verified for quality and consistency
  
• Free from lipid peroxides and environmental pollutants, including heavy metals, pesticides, dioxins, PCBs, and other harmful compounds.
  
• Sourced from wild anchovies, sardines, and/or mackerel, among the best natural sources of EPA and DHA.
  
• Harvested using sustainable fishing practices

This highly potent combination of CoQ10 and EPA/DHA omega-3 fatty acids provides cardiovascular and cognitive benefits through multiple distinct and overlapping pathways. CoQ10 and EPA/DHA have been shown to improve endothelial function, particularly in populations at risk for atherosclerosis (high BMI, metabolic syndrome, smoking, hyperlipidemia), with clinically significant hypotensive and anti-atherogenic effects.

CoQ10 plays a critical role in oxidative phosphorylation and mitochondrial bioenergetics, essential for neuronal health and preventing mitochondrial dysfunction that underlies many chronic diseases, including neurodegenerative diseases. Furthermore, recent data highlights the emerging role of CoQ10 in reducing inflammation and insulin resistance, which are strong contributors to impaired cognitive function. A meta-analysis of randomized trials has shown that CoQ10 and EPA/DHA supplementation reduces key biomarkers of inflammation, including C-reactive protein, TNF-alpha, and IL-6. Serum CoQ10 levels have also been associated with neurological outcomes after ischemic stroke, as well as the risk of disabling dementia.

OptiMega-3 Q10 also provides high doses of pharmaceutical-grade EPA/DHA, which have been shown to reduce numerous cardiovascular risk factors and improve vascular function, with controlled clinical trials demonstrating a reduction in cardiovascular and coronary event rates, particularly in high-risk individuals. Omega-3 fatty acids have been associated with a reduction in myocardial infarctions and strokes, with supplementation attenuating negative left ventricular changes, myocardial fibrosis, and systemic inflammation after myocardial infarction. EPA/DHA supports cognitive function through multiple mechanisms, as both are essential for neuronal membranes, with lower levels being not only a marker of neurological disease but also a risk factor for cognitive impairment.